>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Initial Reaction to Final ACO Rule

Monday, October 31, 2011

Based on ASA's quick, preliminary analysis of the Accountable Care Organization (ACO) final regulations, it does not seem that anesthesiologists and specialists, in general, will have much of a role in ACOs.  While CMS made significant changes in the final rule, the program is still directed toward primary care. We will be posting a more comprehensive analysis of the changes in the final rule based on ASA’s comment letter to CMS on the proposed regulations.

To learn more about ACOs, visit ASA's ACO page.

« Back to Washington Alerts